Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer

DOI Full Paper Access

71

Citations

25

References

2018

Year

Pei‐Chih Lee, Yueh‐Fu Fang, Hirohito Yamaguchi, Wei‐Jan Wang, Tse-Ching Chen, Xuan Hong, Baozhen Ke, Weiya Xia, Yongkun Wei, Zhengyu Zha,

MedicineReceptor Tyrosine KinaseTherapeutic StrategyEgfr Inhibitor ResistanceBronchial NeoplasmEgfr-mutant Lung CancerRadiation OncologyOncologyCell BiologyLung CancerCancer Growth

References

	Year	Citations

Page 1

Page 1